Market Research Logo

Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2017

Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Gastric Cancer patients study in a new report ‘Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Gastric Cancer epidemiology, Gastric Cancer diagnosed patients, and Gastric Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Gastric Cancer derived from epidemiological analysis, percentage of patients diagnosed with Gastric Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Gastric Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Gastric Cancer prevalence, Gastric Cancer diagnosis rate, and Gastric Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Gastric Cancer Patient Flow
  • Gastric Cancer Prevalence
  • Gastric Cancer Diagnosed Patients
  • Gastric Cancer Treated Patients


1. Gastric Cancer: Disease Definition
2. Global Gastric Cancer Patient Flow
2A. Global Gastric Cancer Prevalence
2B. Global Gastric Cancer Diagnosed Patients
2C. Global Gastric Cancer Treated Patients
3. Gastric Cancer Patient Flow in the US
3A. Gastric Cancer Prevalence in the US
3B. Gastric Cancer Diagnosed Patients in the US
3C. Gastric Cancer Treated Patients in the US
4. Gastric Cancer Patient Flow in Europe
4A. Gastric Cancer Prevalence in Europe
4B. Gastric Cancer Diagnosed Patients in Europe
4C. Gastric Cancer Treated Patients in Europe
5. Gastric Cancer Patient Flow in Germany
5A. Gastric Cancer Prevalence in Germany
5B. Gastric Cancer Diagnosed Patients in Germany
5C. Gastric Cancer Treated Patients in Germany
6. Gastric Cancer Patient Flow in France
6A. Gastric Cancer Prevalence in France
6B. Gastric Cancer Diagnosed Patients in France
6C. Gastric Cancer Treated Patients in France
7. Gastric Cancer Patient Flow in Spain
7A. Gastric Cancer Prevalence in Spain
7B. Gastric Cancer Diagnosed Patients in Spain
7C. Gastric Cancer Treated Patients in Spain
8. Gastric Cancer Patient Flow in Italy
8A. Gastric Cancer Prevalence in Italy
8B. Gastric Cancer Diagnosed Patients in Italy
8C. Gastric Cancer Treated Patients in Italy
9. Gastric Cancer Patient Flow in UK
9A. Gastric Cancer Prevalence in UK
9B. Gastric Cancer Diagnosed Patients in UK
9C. Gastric Cancer Treated Patients in UK
10. Gastric Cancer Patient Flow in Japan
10A. Gastric Cancer Prevalence in Japan
10B. Gastric Cancer Diagnosed Patients in Japan
10C. Gastric Cancer Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Gastric Cancer Patient Flow, 2016
Table 2: Global Gastric Cancer Patient Flow Forecast, 2016 - 2025
Table 3: Gastric Cancer Patient Flow in the US, 2016
Table 4: Gastric Cancer Patient Flow Forecast in the US, 2016 - 2025
Table 5: Gastric Cancer Patient Flow in Europe, 2016
Table 6: Gastric Cancer Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Gastric Cancer Patient Flow in Germany, 2016
Table 8: Gastric Cancer Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Gastric Cancer Patient Flow in France, 2016
Table 10: Gastric Cancer Patient Flow Forecast in France, 2016 - 2025
Table 11: Gastric Cancer Patient Flow in Spain, 2016
Table 12: Gastric Cancer Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Gastric Cancer Patient Flow in Italy, 2016
Table 14: Gastric Cancer Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Gastric Cancer Patient Flow in UK, 2016
Table 16: Gastric Cancer Patient Flow Forecast in UK, 2016 - 2025
Table 17: Gastric Cancer Patient Flow in Japan, 2016
Table 18: Gastric Cancer Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Gastric Cancer Patient Flow, 2016
Figure 2: Global Gastric Cancer Patient Flow Forecast, 2016 - 2025
Figure 3: Gastric Cancer Patient Flow in the US, 2016
Figure 4: Gastric Cancer Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Gastric Cancer Patient Flow in Europe, 2016
Figure 6: Gastric Cancer Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Gastric Cancer Patient Flow in Germany, 2016
Figure 8: Gastric Cancer Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Gastric Cancer Patient Flow in France, 2016
Figure 10: Gastric Cancer Patient Flow Forecast in France, 2016 - 2025
Figure 11: Gastric Cancer Patient Flow in Spain, 2016
Figure 12: Gastric Cancer Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Gastric Cancer Patient Flow in Italy, 2016
Figure 14: Gastric Cancer Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Gastric Cancer Patient Flow in UK, 2016
Figure 16: Gastric Cancer Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Gastric Cancer Patient Flow in Japan, 2016
Figure 18: Gastric Cancer Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report